Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Key International (BKYI) Shares Outstanding (Weighted Average) (2016 - 2025)

Bio Key International's Shares Outstanding (Weighted Average) history spans 16 years, with the latest figure at $5.8 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 233.24% year-over-year to $5.8 million; the TTM value through Sep 2025 reached $5.8 million, up 233.24%, while the annual FY2024 figure was $2.1 million, 267.65% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $5.8 million at Bio Key International, up from $5.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $8.1 million in Q3 2022 and bottomed at $436821.0 in Q4 2022.
  • The 5-year median for Shares Outstanding (Weighted Average) is $4.7 million (2025), against an average of $4.2 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) surged 310.07% in 2021 before it tumbled 94.39% in 2022.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $7.8 million in 2021, then crashed by 94.39% to $436821.0 in 2022, then rose by 28.26% to $560278.0 in 2023, then soared by 267.65% to $2.1 million in 2024, then skyrocketed by 179.34% to $5.8 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Shares Outstanding (Weighted Average) are $5.8 million (Q3 2025), $5.3 million (Q2 2025), and $4.7 million (Q1 2025).